CING Cingulate Inc. Common Stock

XNAS 4.66 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

CING $4.66 —
Key stats
$4.66
After hours $4.66 +0.00%
52-Week Range
$3.16 – $11.89
YTD
+6.39%
IV Rank (30D)
16.84
Straddle Price
$3.10
P/C Vol Ratio
2.49
Market Cap
$0.1B
Open
$4.60
Day Range
$4.60 – $4.82
Volume
77,949
Prev Close
$4.66
Fair Value
MODEL: LONG

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)5.15%
Beta vs SPY1.74
Cost of Equity (CAPM)14.72% (VRP-adj)
WACC14.72%
Volatility Risk Premium+152.0pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.0B
Return on Equity (TTM)-122.7%
Book / Price57.3% — banking bias active (P/B is primary)
Debt / Equity0.00
Quality Score1/6 — cyclical/struggling (5y DCF)
SMA 50$5.04 (Market Anchor value)
SMA 20 / Bollinger Mid$4.74
Bollinger Width / SMA20349.8% (drives anchor stability)
Net Debt$-0.0B
Market Cap$0B
Peers used for multiples: ABT, NVS, PFE (SIC-code peers; ETF co-membership was sector-incoherent)
60-Day Conviction
98%
20-Day Fair Value
≈ by Nov 20, 2026
$4.69
α +0.6% rank 83%
conviction
42%
40-Day Fair Value
≈ by Dec 21, 2026
$4.89
α +4.9% rank 88%
conviction
98%
60-Day Fair Value
≈ by Jan 19, 2027
$4.93
α +5.8% rank 84%
conviction
98%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 39.6× · 3 peers
Peer EV/EBITDA n/a 0% median 19.0× · 3 peers
Peer P/B $9.27 21% median 3.5× · 3 peers
Peer P/S n/a 0% median 3.8× · 3 peers
Market Anchor (SMA50) $5.04 79% stability 71% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-10-22 · updated
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834) · industry map
Exchange
XNAS
Market Cap
$0.1B
Employees
14
List Date
2021-12-08
CIK
0001862150
Next Earnings
2026-11-12 (After-Close)
EPS Forecast
($0.48) (4 est.)
Headquarters
Kansas City, KS
Homepage
https://www.cingulate.com

Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses o…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'21'22'23'24'25'26Avg
Jan---36.43%-5.81%-53.87%-10.78%31.05%-15.17%
Feb---23.53%84.54%-59.97%-8.85%2.62%-1.04%
Mar--45.93%-36.45%-17.91%8.86%-5.05%-0.92%
Apr---12.43%8.00%-15.85%-0.94%-14.31%-7.11%
May---25.34%-18.75%-32.60%-8.84%-22.53%-21.61%
Jun--25.86%2.40%-54.80%2.26%51.94%5.53%
Jul---16.89%-46.56%2.65%25.12%-20.17%-11.17%
Aug--30.95%15.90%94.53%-21.76%7.04%25.33%
Sep---30.97%10.78%-28.00%5.09%-3.13%-9.25%
Oct---1.82%-37.87%-17.89%-9.55%-1.89%*-13.80%
Nov---8.93%-23.54%13.25%-1.84%---5.26%
Dec-37.98%2.80%25.00%14.65%19.89%--4.87%
Total-37.98%-59.69%-59.56%-94.04%-10.48%4.60%-42.86%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $4.72
SMA 50: $5.03
SMA 200: $5.43
Current: $4.69
EMA 12: $4.64
EMA 26: $4.77
MACD: -0.1327 | Signal: -0.0011
BEARISH
ADX (14): 28.46
TREND
+DI: 16.14
−DI: 23.78

Momentum Oscillators

RSI (14): 46.00
NEUTRAL
Stoch %K: 57.58
Stoch %D: 45.25
Williams %R: -35.23

Volume & Volatility

BB Upper: $5.09
BB Lower: $4.36
NEUTRAL
OBV: -4,762,316
Vol SMA 20: 99,961
Vol ROC: -7.72%
ATR: $0.25
True Range: $0.22
HV 20: 37.5%
HV 30: 35.5%
HV 60: 40.1%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-23T00:00:00 – 2026-10-21T00:00:00
AI Analysis

LLM Stock Analysis Report

SYMBOL: CING

Executive Summary Overall Assessment: BEARISH (Confidence Level: 6/10)

Key Drivers:

  • Weak technical signals, including a bearish MACD
  • High volatility, with beta exceeding 1.47
  • Recent news headlines are mixed, but overall sentiment is negative

Primary Risks:

  • Continued market downturn affecting the biotech sector
  • Weaker-than-expected earnings or pipeline updates

Investment Thesis: CING's stock price may continue to decline due to a combination of technical and fundamental factors.

Recent News Sentiment Impact: The positive news headlines, such as the management team update and patent issuance, have had limited impact on the stock price. The negative headline about WD-40 shares trading higher has contributed to the bearish sentiment.

Technical Analysis

Trend Direction:

  • Short-term: BEARISH (1-4 weeks)
  • Medium-term: NEUTRAL (1-3 months)
  • Long-term: NEUTRAL (3-12 months)

Support/Resistance Levels: The stock is trading below the SMA 20 and EMA 12, indicating potential resistance.

Momentum Signals:

  • RSI interpretation: NEUTRAL (47.02), no oversold or overbought conditions
  • MACD signal: BEARISH (crossover above signal line)
  • Bollinger Bands position: NEUTRAL (squeeze)

Volume Analysis: The volume has been declining, indicating a lack of interest in the stock.

News & Sentiment Analysis

Recent Headlines Summary: The headlines are mixed, with some positive updates and one negative article about WD-40 shares trading higher.

Sentiment Assessment: Overall sentiment is NEGATIVE due to the bearish MACD signal and high volatility.

Catalyst Identification: Earnings date: No earnings data available

Market Narrative: The news headlines have not significantly impacted the stock price, which is primarily driven by technical factors.

Risk & Volatility Assessment

Beta Interpretation: High risk relative to market (beta > 1.47)

Volatility Regime: High volatility - stock moves more than market

Options Market Signals:

  • IV rank: 0.0% (Low)
  • Put/call ratios: Bullish sentiment
  • Unusual activity: None

Downside Protection: Support levels and risk management considerations should be evaluated.

Market Context & Positioning

Sector Performance: The biotech sector is experiencing a downturn, which may affect CING's stock price.

Institutional Activity: No significant institutional interest signals are present.

Correlation Analysis: CING's stock price is not strongly correlated with the market (R-squared interpretation).

Relative Valuation: Position within trading range should be considered.

Key Levels & Action Items

Critical Price Levels:

  • Support: $4.19
  • Resistance: $5.69

Breakout/Breakdown Levels:

  • Breakout level: $5.92
  • Breakdown level: $3.49

Time-Sensitive Catalysts: Earnings date: No earnings data available

Risk Management: Stop-loss levels and position sizing considerations should be evaluated.

Please note that this is a comprehensive analysis report, and you should review the data carefully before making any investment decisions.

Generated
Earnings History
1 of 1 under expected move
Avg Expected Move
19.04%
Avg Actual Move
2.00%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2026-08-13 After-Close 19.04% 2.00% 0.11x Within

Earnings calendar: this week’s reports with expected vs actual moves →

CING Options Activity & IV Rank

CING IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 98.6%
7-DTE IV: —
Expected Move: $3.10
7-DTE Move: $3.10
Days to Exp: 29 (2026-11-20)

Options Flow

Call Volume: 171
Put Volume: 425
P/C Volume: 2.485
BEARISH
Call OI: 2,961
Put OI: 2,240
P/C OI: 0.757
Total OI: 5,201

ATM Options Pricing

ATM Call: $2.50
ATM Put: $0.60
Call %: 53.6%
Put %: 12.9%

Chain Summary

Chain Volume: 2,794
Chain OI: 14,392
Last Updated: 10/22/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
HIGH γ vs HISTORY

Estimated net dealer gamma is at the 88th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
88%
vs own history
GEX tilt
+1.00
OI-weighted, today
Vanna tilt
+1.00
δ-sensitivity to IV
Charm tilt
-1.00
δ-decay vs time
Vanna tilt +1.00: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -1.00: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 3 ATM contracts, 10k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
No data
30 DTE / 10d —
— pts EXTREME
ATM 93.2% / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)16.8LowOct 22
Straddle Price (30 DTE)$3.10Oct 22
Beta Analysis

Risk Metrics

Beta: 1.3223
Alpha: 44.24%
Correlation: 0.1928
R-Squared: 3.7%
Stock Volatility: 87.4%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own CING
1 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Renaissance Technologies Hedge fund
Jim Simons
$697K
0.00%
#2471 of 3138+299.8%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

CING Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 8,787,200 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

33 filers1,981,382 shares$10.54M value22.55% of float
# Filer Shares Value % of Total % of Float Period
1 Vanguard Capital Management LLC 570,873 $3.12M 29.63% 6.50% 2026-06-30
2 Raymond James Financial, Inc. Custodian 166,898 $912.93K 8.66% 1.90% 2026-06-30
3 Chicago Partners Investment Group LLC 188,429 $912.00K 8.65% 2.14% 2026-06-30
4 Kestra Advisory Services, LLC 151,500 $828.71K 7.86% 1.72% 2026-06-30
5 Geode Capital Management, LLC Custodian 144,636 $791.37K 7.51% 1.65% 2026-06-30
6 RENAISSANCE TECHNOLOGIES LLC 127,500 $697.42K 6.62% 1.45% 2026-06-30
7 Vanguard Group Inc Custodian 151,433 $657.22K 6.24% 1.72% 2025-12-31
8 Vanguard Fiduciary Trust Co 79,160 $433.00K 4.11% 0.90% 2026-06-30
9 BlackRock, Inc. Custodian 53,130 $290.62K 2.76% 0.60% 2026-06-30
10 BCV Asset Management Inc. 51,200 $272.94K 2.59% 0.58% 2026-06-30
11 State Street Corp 47,888 $261.95K 2.49% 0.55% 2026-06-30
12 Northern Trust Corp Custodian 35,121 $192.11K 1.82% 0.40% 2026-06-30
13 Quantum Private Wealth, LLC 30,000 $164.10K 1.56% 0.34% 2026-06-30
14 Prospera Financial Services Inc 29,900 $163.55K 1.55% 0.34% 2026-06-30
15 Jane Street Group, LLC Custodian 28,878 $157.96K 1.50% 0.33% 2026-06-30
16 UBS Group AG Custodian 25,947 $141.93K 1.35% 0.30% 2026-06-30
17 Mariner, LLC 21,281 $116.41K 1.10% 0.24% 2026-06-30
18 XTX Topco Ltd 20,818 $113.87K 1.08% 0.24% 2026-06-30
19 Jump Financial, LLC 14,638 $80.07K 0.76% 0.17% 2026-06-30
20 Virtu Financial LLC 12,056 $66.00K 0.63% 0.14% 2026-06-30
21 PKS Advisory Services, LLC 11,500 $62.91K 0.60% 0.13% 2026-06-30
22 Vanguard Global Advisers, LLC 4,743 $25.94K 0.25% 0.05% 2026-06-30
23 Morgan Stanley Custodian 4,263 $23.32K 0.22% 0.05% 2026-06-30
24 OSAIC HOLDINGS, INC. Custodian 2,292 $12.54K 0.12% 0.03% 2026-06-30
25 Jones Financial Companies LLLP Custodian 2,000 $9.92K 0.09% 0.02% 2026-06-30
3 filers$1.17M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $778.38K 66.50% 2026-06-30
2 Jane Street Group, LLC Custodian $294.29K 25.14% 2026-06-30
3 Citadel Advisors LLC Custodian $97.91K 8.36% 2026-06-30
3 filers$1.62M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $1.20M 73.93% 2026-06-30
2 Jane Street Group, LLC Custodian $213.33K 13.19% 2026-06-30
3 Citadel Advisors LLC Custodian $208.41K 12.88% 2026-06-30

CING Insider Trading (Form 4)

Latest: 2026-10-02
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-10-02 Raul R. Silva EVP and CSO Grant (A) +4,293 opt — EDGAR
2026-07-20 Thomas Jeffrey Hargroves Director Grant (A) +20,000 opt — EDGAR
2026-07-20 Matthew Brams EVP and Chief Medical Officer Grant (A) +80,000 opt — EDGAR
2026-07-20 Jennifer L. Callahan EVP and CFO Grant (A) +60,000 opt — EDGAR
2026-07-20 Bryan Jay Lawrence Director Grant (A) +20,000 opt — EDGAR
2026-07-20 Bryan Wade Downey EVP & Chief Commercial Officer Grant (A) +100,000 opt — EDGAR
2026-07-20 Peter J. Werth Director Grant (A) +20,000 opt — EDGAR
2026-07-20 Raul R. Silva EVP and CSO Grant (A) +80,000 opt — EDGAR
2026-07-20 Shane J. Schaffer Chief Executive Officer Grant (A) +295,000 opt — EDGAR
2026-07-02 Raul R. Silva EVP and CSO Grant (A) +3,885 opt — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

CING Board & Officers

As of SEC filings through Oct 2, 2026

Directors 3

Officers 6

Changes in the last 10 years (42)
May 18, 2026The company announced the departure of John A Roberts from the board in an SEC filing
May 18, 2026The company announced the departure of Jeffrey S Ervin from the board in an SEC filing
Mar 11, 2026Jennifer L. Callahan listed as EVP and CFO (previously SVP and CFO) in SEC filings
Nov 3, 2025Bryan Wade Downey became Chief Commercial Officer
Aug 7, 2025The company announced the departure of Laurie Myers as EVP and COO in an SEC filing
Jul 8, 2025Nilay Dahyabhai Patel became CLO & Cco
Jun 23, 2025Peter J. Werth no longer listed as a 10% owner in SEC filings
Mar 6, 2024Jennifer L. Callahan listed as SVP and CFO (previously Corporate Controller) in SEC filings
Feb 12, 2024John A Roberts became a director
Feb 12, 2024Jeffrey S Ervin became a director
Feb 12, 2024Bryan Jay Lawrence became a director
Dec 13, 2023The company announced the departure of Louis G Van Horn as EVP and CFO in an SEC filing
Dec 13, 2023The company announced the departure of Gregg Wm Givens from the board in an SEC filing
Dec 13, 2023The company announced the departure of Curtis Medeiros from the board in an SEC filing
Dec 12, 2023The company announced the departure of Patrick Joseph Gallagher from the board in an SEC filing
Dec 12, 2023The company announced the departure of Craig S. Gilgallon as EVP and General Counsel in an SEC filing
Dec 6, 2023The company announced the departure of Scott Applebaum from the board in an SEC filing
Sep 11, 2023Peter J. Werth first listed as a 10% owner in an SEC filing
Jan 5, 2023The company announced the departure of Jeffrey X Conroy from the board in an SEC filing
Sep 23, 2022The company announced the departure of Thomas Jeffrey Hargroves from the board in an SEC filing
Not reported recently (2)
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
3 ETFs hold CING
3 shown · $2.87M total exposure · 0.01% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $2.0M — 2026-09-30
2 VXF Vanguard Extended Market ETF Vanguard 0.00% $793,960 — 2026-09-30
3 IWC iShares Micro-Cap ETF iShares (BlackRock) 0.01% $127,510 $1.2B 2026-10-20
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-3.68
TTM Revenue
$0.00
TTM Net Income
$-28.80M
TTM Op. Cash Flow
$-20.65M
Quarterly figures (2 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q2 '262026-06-30$0.00$-5.87M$-0.45$-5.90M
Q2 '252025-06-30$0.00$-4.98M$-1.14$-4.80M
Q2 2026 • period ending 2026-06-30 • filed 2026-08-13
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
1.74
P/S
—
EV/EBITDA
—
EV/Sales
—
ROE
-122.7%
ROA
-87.1%
Div Yield
0.00%
FCF Yield
-50.44%
Debt/Equity
0.00
Current Ratio
—
Market Cap
$40.95M
as of 2026-10-22
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
1.03M
SI % of Float
11.64%
Days to Cover
10.49
Short Vol Ratio
42.3%
Free Float
8.86M
Float %
65.8%
Short interest 2026-09-30 • Short volume 2026-10-21 • Float 2026-05-15